Lightbridge Provides Business Update and Announces Second Quarter 2025 Financial Results
Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, reported significant progress in Q2 2025 along with financial results. The company achieved key milestones including successful co-extrusion demonstration at Idaho National Laboratory and completion of final experiment design review for upcoming irradiation testing.
Financial highlights show a strong position with $97.9 million in cash and cash equivalents and $97.2 million in working capital as of June 30, 2025. The company reported a net loss of $3.5 million for Q2 2025, compared to $2.4 million in Q2 2024, primarily due to increased R&D and administrative expenses. R&D expenses increased to $1.6 million, up from $0.9 million in the same quarter last year.
Lightbridge Corporation (Nasdaq: LTBR), società specializzata in tecnologie avanzate per combustibili nucleari, ha annunciato progressi significativi nel Q2 2025 e i relativi risultati finanziari. Tra i traguardi raggiunti figurano la dimostrazione con successo della co-estrusione presso l'Idaho National Laboratory e il completamento della revisione finale del progetto sperimentale per i test di irraggiamento imminenti.
I dati finanziari evidenziano una posizione solida, con $97,9 milioni in contanti e mezzi equivalenti e $97,2 milioni di capitale circolante al 30 giugno 2025. L'azienda ha riportato una perdita netta di $3,5 milioni nel Q2 2025, rispetto a $2,4 milioni nel Q2 2024, principalmente a causa dell'aumento delle spese di ricerca e sviluppo e amministrative. Le spese di R&S sono salite a $1,6 milioni, da $0,9 milioni nello stesso trimestre dell'anno precedente.
Lightbridge Corporation (Nasdaq: LTBR), una empresa de tecnología avanzada para combustibles nucleares, informó avances significativos en el Q2 2025 junto con sus resultados financieros. Entre los hitos alcanzados se incluye la demostración exitosa de co-extrusión en el Idaho National Laboratory y la finalización de la revisión del diseño experimental para las próximas pruebas de irradiación.
Los aspectos financieros muestran una posición sólida con $97,9 millones en efectivo y equivalentes de efectivo y $97,2 millones de capital de trabajo al 30 de junio de 2025. La compañía registró una pérdida neta de $3,5 millones en el Q2 2025, frente a $2,4 millones en el Q2 2024, principalmente debido al aumento de los gastos de I+D y administrativos. Los gastos de I+D aumentaron a $1,6 millones, desde $0,9 millones en el mismo trimestre del año anterior.
Lightbridge Corporation (Nasdaq: LTBR)은 첨단 원자력 연료 기술 기업으로 2025년 2분기(Q2 2025)에 의미 있는 진전을 보고하고 재무 결과를 발표했습니다. 회사는 아이다호 국립연구소(Idaho National Laboratory)에서의 공동 압출(co-extrusion) 시연 성공과 예정된 조사(irradiation) 시험을 위한 최종 실험 설계 검토 완료 등 주요 이정표를 달성했습니다.
재무 요약에 따르면 2025년 6월 30일 기준 $97.9 million의 현금 및 현금성자산과 $97.2 million의 운전자본을 보유해 재무 상태가 견조합니다. 회사는 2025년 2분기에 $3.5 million의 순손실을 기록했으며(2024년 2분기 $2.4 million), 이는 주로 연구개발 및 관리비 증가에 따른 것입니다. 연구개발비는 같은 분기 전년의 $0.9 million에서 $1.6 million으로 증가했습니다.
Lightbridge Corporation (Nasdaq: LTBR), société spécialisée dans les technologies avancées de combustible nucléaire, a annoncé des progrès significatifs au T2 2025 ainsi que ses résultats financiers. Les étapes clés comprennent la démonstration réussie de co-extrusion au Idaho National Laboratory et l'achèvement de la revue finale de la conception expérimentale pour les prochains essais d'irradiation.
Les points financiers montrent une position solide avec 97,9 millions de dollars en liquidités et équivalents de liquidités et 97,2 millions de dollars de fonds de roulement au 30 juin 2025. La société a enregistré une perte nette de 3,5 millions de dollars pour le T2 2025, contre 2,4 millions de dollars au T2 2024, principalement en raison de l'augmentation des dépenses de recherche et développement et des frais administratifs. Les dépenses de R&D ont augmenté à 1,6 million de dollars, contre 0,9 million de dollars au même trimestre de l'année précédente.
Lightbridge Corporation (Nasdaq: LTBR), ein Unternehmen für fortschrittliche Kernbrennstofftechnologie, meldete im Q2 2025 erhebliche Fortschritte sowie finanzielle Ergebnisse. Zu den erreichten Meilensteinen zählen die erfolgreiche Co-Extrusions-Demonstration im Idaho National Laboratory und der Abschluss der finalen Überprüfung des Versuchsdesigns für die bevorstehenden Bestrahlungstests.
Die finanziellen Kennzahlen zeigen eine solide Lage mit $97,9 Millionen an liquiden Mitteln und Zahlungsmitteln und $97,2 Millionen an Working Capital zum 30. Juni 2025. Das Unternehmen verzeichnete im Q2 2025 einen Nettoverlust von $3,5 Millionen gegenüber $2,4 Millionen im Q2 2024, was hauptsächlich auf höhere F&E- und Verwaltungskosten zurückzuführen ist. Die F&E-Aufwendungen stiegen auf $1,6 Millionen gegenüber $0,9 Millionen im gleichen Quartal des Vorjahres.
- Strong cash position with $97.9 million in cash and equivalents, up from $40.0 million at end of 2024
- Successful technical milestones achieved including co-extrusion demonstration and final experiment design review
- Inclusion in Russell 2000® and Russell 3000® Indexes, enhancing institutional investor visibility
- Favorable political environment with new Executive Orders supporting nuclear technologies
- Net loss increased to $3.5 million in Q2 2025, up from $2.4 million in Q2 2024
- R&D expenses increased 78% to $1.6 million from $0.9 million year-over-year
- General and administrative expenses rose 39% to $2.5 million from $1.8 million year-over-year
Insights
Lightbridge's nuclear fuel development progresses with strong $97.9M cash position despite widening losses as R&D investment accelerates.
Lightbridge's Q2 2025 results showcase a significantly strengthened balance sheet with
The company is accelerating its R&D expenditures, which increased
However, the increased R&D pace has widened Lightbridge's losses. Q2 net loss grew to
The political environment appears increasingly supportive, with executive orders focusing on power uprates and advanced nuclear technologies - both potential tailwinds for Lightbridge's fuel technology, which aims to improve power output and safety in existing and new reactors. Their inclusion in the Russell 2000® and Russell 3000® Indexes may enhance institutional investor visibility.
While cash burn has increased to
RESTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter ended June 30, 2025, and provided an update on the Company’s continued progress.
Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “The six months of 2025 marked a period of exceptional progress for Lightbridge as we advanced our nuclear fuel technology. We achieved several critical milestones that position us strongly for the future, including successful co-extrusion demonstration at Idaho National Laboratory in February, completing the final experiment design review in June for our upcoming irradiation testing in the Advanced Test Reactor, and, most recently, successful fabrication of enriched uranium-zirconium alloy coupon samples that will undergo irradiation testing.”
“The political environment has become increasingly favorable for nuclear energy, with President Trump’s nuclear energy Executive Orders in May including a focus on power uprates and federal support for advanced nuclear technologies. Our inclusion in the Russell 2000® and Russell 3000® Indexes validates our progress and enhances our visibility among institutional investors. As we look ahead, we are well-positioned to benefit from the Fission Accelerated Steady-state Testing (FAST) method at Idaho National Laboratory, which we expect will expedite our irradiation testing timeline. We remain on track to generate the critical performance data needed to support our regulatory licensing efforts and commercial deployment of Lightbridge Fuel,” concluded Mr. Grae.
Larry Goldman, Chief Financial Officer of Lightbridge Corporation, commented, “We ended the second quarter of 2025 with a strong financial position, including
Financial Highlights
Working capital was
Cash Flows Summary
Cash and cash equivalents were
- Cash used in operating activities for the six months ended June 30, 2025, was
$5.6 million , an increase of$1.9 million compared to$3.7 million for the six months ended June 30, 2024. The increase was primarily due to increased spending on research and development (R&D) and general and administrative expenses.
- Cash provided by financing activities for the six months ended June 30, 2025, was
$63.5 million , an increase of$61.3 million compared to$2.2 million for the six months ended June 30, 2024. This increase was primarily due to an increase in the net proceeds received from the issuance of common stock under our at-the-market facility of$60.9 million and net proceeds from the exercise of stock options of$0.6 million , partially offset by an increase in net share settlement of equity awards for the payment of withholding taxes of$0.2 million .
Balance Sheet Summary
Total assets were
- Stockholders’ equity was
$97.8 million at June 30, 2025, as compared to$40.5 million at December 31, 2024.
Second Quarter 2025 Operations Summary
- General and administrative expenses amounted to
$2.5 million for the second quarter ended June 30, 2025, compared to$1.8 million for the second quarter ended June 30, 2024. The increase of$0.7 million was primarily due to an increase in IT services fees of$0.1 million , an increase in subscription expense of$0.1 million , an increase in professional fees of$0.3 million , and an increase in stock-based compensation of$0.2 million .
- Lightbridge’s total R&D expenses amounted to
$1.6 million for the second quarter ended June 30, 2025, compared to$0.9 million for the second quarter ended June 30, 2024, an increase of$0.7 million . This increase was due to the increase in R&D activities related to the development of Lightbridge Fuel. This increase primarily consisted of an increase in Idaho National Laboratories (INL) project labor costs of$0.5 million , an increase in allocated employee compensation and stock-based compensation expenses of$0.1 million and an increase of other R&D expenses of$0.2 million offset by a decrease in R&D expenses related to the Romania feasibility study of$0.1 million , which study was completed in 2024.
- Total other income was
$0.6 million for the second quarter ended June 30, 2025, compared to$0.3 million for the second quarter ended June 30, 2024. Other income consisted of interest income earned from the purchase of treasury bills and our bank savings account.
- Net loss was
$3.5 million for the second quarter ended June 30, 2025, compared to$2.4 million for the second quarter ended June 30, 2024.
The Six Months Ended June 30, 2025 - Operations Summary
- General and administrative expenses amounted to
$6.0 million for the six months ended June 30, 2025, compared to$4.0 million for the six months ended June 30, 2024. The increase of$2.0 million was primarily due to an increase in consulting fees of$0.1 million , an increase in IT services fees of$0.1 million , an increase in professional fees of$0.7 million , an increase in employee compensation and employee benefits of$0.2 million , and an increase in stock-based compensation of$0.9 million primarily due to the accelerated vesting of restricted stock awards issued to a former employee of$0.5 million .
- Lightbridge’s total R&D expenses amounted to
$3.3 million for the six months ended June 30, 2025, compared to$1.9 million for the six months ended June 30, 2024, an increase of$1.4 million . This increase primarily consisted of an increase in INL project labor costs of$0.9 million , an increase in allocated employee compensation and stock-based compensation expenses of$0.7 million , and an increase in IT services fees of$0.1 million , partially offset by a decrease in R&D expenses related to the Romania feasibility study and Centrus Energy FEED study of$0.3 million , both of which studies were completed in 2024.
- Total other income was
$1.0 million for the six months ended June 30, 2025, compared to$0.7 million for the six months ended June 30, 2024. Other income consisted of interest income earned from the purchase of treasury bills and our bank savings account.
- Net loss was
$8.3 million for the six months ended June 30, 2025, compared to$5.2 million for the six months ended June 30, 2024.
CONFERENCE CALL & AUDIO WEBCAST
Lightbridge will host a conference call on Tuesday, August 12, at 4:00 p.m. ET to discuss the Company’s financial results and provide an update on its fuel development activities. The conference call will be led by Seth Grae, President & Chief Executive Officer, with other Lightbridge executives available to answer questions.
To access the call by phone, please register using this link (registration link), and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes before the scheduled start time. The webcast can be accessed at the following link (webcast).
A webcast replay will also be available for a limited time at the following link (webcast replay).
About Lightbridge Corporation
Lightbridge Corporation (NASDAQ: LTBR) is focused on developing advanced nuclear fuel technology essential for delivering abundant, zero-emission, clean energy and providing energy security to the world. The Company is developing Lightbridge Fuel™, a proprietary next-generation nuclear fuel technology for existing light water reactors and pressurized heavy water reactors, significantly enhancing reactor safety, economics, and proliferation resistance. The Company is also developing Lightbridge Fuel for new small modular reactors (SMRs) to bring the same benefits plus load-following with renewables on a zero-carbon electric grid.
Lightbridge has entered into two long-term framework agreements with Battelle Energy Alliance LLC, the United States Department of Energy’s operating contractor for Idaho National Laboratory, the United States' lead nuclear energy research and development laboratory. DOE’s Gateway for Accelerated Innovation in Nuclear program has twice awarded Lightbridge to support the development of Lightbridge Fuel over the past several years. Lightbridge is participating in two university-led studies through the DOE Nuclear Energy University Program at Massachusetts Institute of Technology and Texas A&M University. An extensive worldwide patent portfolio backs Lightbridge’s innovative fuel technology. Lightbridge is included in the Russell 2000® Index and the Russell 3000® Index. For more information, please visit www.ltbridge.com.
To receive Lightbridge Corporation updates via e-mail, subscribe at https://www.ltbridge.com/investors/news-events/email-alerts
Lightbridge is on YouTube. Subscribe to access past demonstrations, interviews, and other video content at https://www.youtube.com/@lightbridgecorporation
Lightbridge is on X (formerly Twitter). Sign up to follow @LightbridgeCorp at http://twitter.com/lightbridgecorp.
Forward Looking Statements
With the exception of historical matters, the matters discussed herein are forward-looking statements. These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to: Lightbridge’s ability to commercialize its nuclear fuel technology; the degree of market adoption of Lightbridge’s product and service offerings; Lightbridge’s ability to fund general corporate overhead and outside research and development costs; market competition; our ability to attract and retain qualified employees; dependence on strategic partners; demand for fuel for nuclear reactors; Lightbridge’s ability to manage its business effectively in a rapidly evolving market; the availability of nuclear test reactors and the risks associated with unexpected changes in Lightbridge’s fuel development timeline; the increased costs associated with metallization of Lightbridge’s nuclear fuel; public perception of nuclear energy generally; changes in the political environment; risks associated with war in Europe; changes in the laws, rules and regulations governing Lightbridge’s business; development and utilization of, and challenges to, Lightbridge’s intellectual property; risks associated with potential shareholder activism; potential and contingent liabilities; as well as other factors described in Lightbridge's filings with the Securities and Exchange Commission (the “SEC”). Lightbridge does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements.
A further description of risks and uncertainties can be found in Lightbridge’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in its other filings with the SEC, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Statements”, all of which are available at http://www.sec.gov/ and www.ltbridge.com.
Investor Relations Contact:
Matthew Abenante, IRC
Director of Investor Relations
Tel: +1 (347) 947-2093
ir@ltbridge.com
LIGHTBRIDGE CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
June 30, | December 31, | ||||||
2025 | 2024 | ||||||
ASSETS | |||||||
Current Assets | |||||||
Cash and cash equivalents | $ | 97,901,357 | $ | 39,990,827 | |||
Prepaid expenses and other current assets | 460,913 | 324,378 | |||||
Total Current Assets | 98,362,270 | 40,315,205 | |||||
Other Assets | |||||||
Prepaid project costs and other long-term assets | 491,719 | 528,805 | |||||
Trademarks | 114,981 | 108,865 | |||||
Total Assets | $ | 98,968,970 | $ | 40,952,875 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current Liabilities | |||||||
Accounts payable and accrued liabilities | $ | 1,194,377 | $ | 424,585 | |||
Total Current Liabilities | 1,194,377 | 424,585 | |||||
Stockholders’ Equity | |||||||
Preferred stock, | — | — | |||||
Common stock, | 25,545 | 18,784 | |||||
Additional paid-in capital | 270,225,336 | 204,694,348 | |||||
Accumulated deficit | (172,476,288 | ) | (164,184,842 | ) | |||
Total Stockholders’ Equity | 97,774,593 | 40,528,290 | |||||
Total Liabilities and Stockholders’ Equity | $ | 98,968,970 | $ | 40,952,875 | |||
LIGHTBRIDGE CORPORATION UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
Operating Expenses | |||||||||||||||
General and administrative | $ | 2,502,637 | $ | 1,792,613 | $ | 5,982,647 | $ | 3,950,358 | |||||||
Research and development | 1,639,864 | 909,612 | 3,305,777 | 1,933,435 | |||||||||||
Total Operating Expenses | 4,142,501 | 2,702,225 | 9,288,424 | 5,883,793 | |||||||||||
Operating Loss | (4,142,501 | ) | (2,702,225 | ) | (9,288,424 | ) | (5,883,793 | ) | |||||||
Other Income | |||||||||||||||
Interest income | 622,067 | 327,591 | 996,978 | 689,575 | |||||||||||
Total Other Income | 622,067 | 327,591 | 996,978 | 689,575 | |||||||||||
Net Loss Before Income Taxes | (3,520,434 | ) | (2,374,634 | ) | (8,291,446 | ) | (5,194,218 | ) | |||||||
Income taxes | — | — | — | — | |||||||||||
Net Loss | $ | (3,520,434 | ) | $ | (2,374,634 | ) | $ | (8,291,446 | ) | $ | (5,194,218 | ) | |||
Net Loss Per Common Share | |||||||||||||||
Basic and diluted | $ | (0.16 | ) | $ | (0.17 | ) | $ | (0.40 | ) | $ | (0.38 | ) | |||
Weighted Average Number of Common Shares Outstanding | 22,257,221 | 13,930,032 | 20,909,752 | 13,710,993 | |||||||||||
LIGHTBRIDGE CORPORATION UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
Six Months Ended June 30, | |||||||
2025 | 2024 | ||||||
Operating Activities | |||||||
Net loss | $ | (8,291,446 | ) | $ | (5,194,218 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Stock-based compensation | 2,106,073 | 856,120 | |||||
Changes in operating assets and liabilities: | |||||||
Prepaid expenses and other current assets | (226,535 | ) | (95,605 | ) | |||
Prepaid project costs and other long-term assets | 37,086 | 6,750 | |||||
Accounts payable and accrued liabilities | 769,792 | 701,506 | |||||
Net Cash Used in Operating Activities | (5,605,030 | ) | (3,725,447 | ) | |||
Investing Activities | |||||||
Trademarks | (6,116 | ) | — | ||||
Net Cash Used in Investing Activities | (6,116 | ) | — | ||||
Financing Activities | |||||||
Net proceeds from the issuances of common stock | 63,122,922 | 2,204,623 | |||||
Net proceeds from the exercise of stock options | 633,375 | — | |||||
Payments for taxes related to net share settlement of equity awards | (234,621 | ) | (10,582 | ) | |||
Net Cash Provided by Financing Activities | 63,521,676 | 2,194,041 | |||||
Net Increase (Decrease) in Cash and Cash Equivalents | 57,910,530 | (1,531,406 | ) | ||||
Cash and Cash Equivalents, Beginning of Period | 39,990,827 | 28,598,445 | |||||
Cash and Cash Equivalents, End of Period | $ | 97,901,357 | $ | 27,067,039 | |||
Supplemental Disclosure of Cash Flow Information | |||||||
Cash paid during the period: | |||||||
Interest paid | $ | — | $ | — | |||
Income taxes paid | $ | — | $ | — | |||
Non-Cash Financing Activities: | |||||||
Payment of accrued liabilities with common stock | $ | 15,000 | $ | 15,000 | |||
